
Fibractimin 67mg/10mg Tablet
Marketer
Cogentrix Pharma
Salt Composition
Fenofibrate (67mg) + Rosuvastatin (10mg)
Overview Fibractimin 67mg/10mg Tablet
LipiComb 67mg/10mg tablets combine two lipid-reducing agents to lower elevated cholesterol and triglyceride levels in the bloodstream. This dual-action medication is indicated when lifestyle modifications (like a low-fat diet) prove insufficient. It's designed to mitigate the risk of cardiovascular complications. LipiComb 67mg/10mg can be administered with or without food, at any time of day, but consistent daily timing aids adherence. Dosage is determined individually by your physician, based on lipid profiles and response. While high cholesterol and triglycerides often present without symptoms, discontinuing treatment can elevate lipid levels, exacerbating the condition and raising stroke and heart disease risks. Regular lipid profile monitoring is crucial. This medication complements a comprehensive treatment strategy encompassing a healthy low-fat diet, regular exercise, smoking cessation, moderate alcohol consumption, and weight management. Maintain a generally healthy diet, minimizing high-fat foods. Common, typically mild and transient, side effects include nausea, abdominal discomfort, constipation, headache, flatulence, and myalgia. Persistent symptoms, jaundice, unusual bleeding or bruising, or recurrent/severe muscle pain warrant immediate medical attention. Periodic liver function tests may be recommended. Pre-existing liver disease (indicated by abnormal liver function tests or persistent jaundice), kidney issues, pregnancy, pregnancy planning, or breastfeeding should be disclosed to your physician before initiating treatment. Diabetics should closely monitor blood glucose levels as this medication may elevate blood sugar.
Primary Ingredients of Fibractimin 67mg/10mg Tablet
There is no text provided to rephrase.
Uses of Fibractimin 67mg/10mg Tablet
Preventing heart attacks and managing high cholesterol.
Major Benefits of Fibractimin 67mg/10mg Tablet:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the 67mg/10mg Fibractimin tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, though consistent timing is recommended.
Common Side effects of Fibractimin 67mg/10mg Tablet:
- Headache
- Muscle pain
- Constipation
- Abnormal liver function tests
- Joint pain
- Elevated creatine kinase
- Diabetes
How to use Fibractimin 67mg/10mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment schedule. Ingest the 67mg/10mg Fibractimin tablet whole; avoid chewing, crushing, or breaking it. Consumption may coincide with meals or be taken independently, though consistent timing is preferred.
How Fibractimin 67mg/10mg Tablet works:
Lipofen 67mg/10mg tablets combine fenofibrate and rosuvastatin to reduce elevated lipids. Fenofibrate diminishes blood triglyceride levels, whereas rosuvastatin inhibits the production of low-density lipoprotein (LDL) cholesterol. Concurrently, both medications elevate high-density lipoprotein (HDL) cholesterol concentrations.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Fibractimin 67mg/10mg tablets.
PregnancyUNSAFE
Administering Fibractimin 67mg/10mg tablets during pregnancy poses a substantial risk. Pregnant women should consult their physician; research in both animal and human subjects indicates considerable harm to the fetus.
Breast feedingCONSULT YOUR DOCTOR
The use of Fibractimin 67mg/10mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Fibractimin 67mg/10mg tablets.
KidneyCAUTION
Patients with kidney impairment should use Fibractimin 67mg/10mg Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Fibractimin 67mg/10mg Tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when using Fibractimin 67mg/10mg tablets, potentially requiring dosage modification. A physician's consultation is advised. Fibractimin 67mg/10mg tablets are contraindicated for individuals with severe or active liver disease.
What if you forget to take Fibractimin 67mg/10mg Tablet :
Should you forget a Fibractimin 67mg/10mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Fibractimin 67mg/10mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
